In situ hydrogel nanovaccine based on whole-cell tumor antigen efficiently activates adaptive immunity for the prevention and treatment of ovarian cancer

Infrared Physics & Technology · Elsevier

Аннотация

Publication date: November 2026 Source: Acta Pharmaceutica Sinica B, Volume 16, Issue 11 Author(s): Jia Yan, Ruyi Lin, Qiyu Liu, Yatong Zhang, Hao Chen, Fan Tong, Yujun Song, Yulong Shi, Yuan Li

Читать у издателя →

Похожие статьи